1,331
Views
11
CrossRef citations to date
0
Altmetric
Original Articles

ADVANTAGES OF THE AMDL-ELISA DR-70 (FDP) ASSAY OVER CARCINOEMBRYONIC ANTIGEN (CEA) FOR MONITORING COLORECTAL CANCER PATIENTS

&
Pages 131-147 | Published online: 23 Mar 2010

REFERENCES

  • et al. Promoting early detection tests for colorectal carcinoma and adenomatous polyps: a framework for action: the strategic plan of the National Colorectal Cancer Roundtable . Cancer 2002 , 95 , 1618 – 1628 .
  • Ladabaum , U. ; Song , K. Projected national impact of colorectal cancer screening on clinical and economic outcomes and health services demand . Gastroenterology 2005 , 129 , 1151 – 1162 .
  • Hill , L.B. ; O'Connell , J.B. ; Ko , C.Y. Colorectal cancer: epidemiology and health services research . Surg. Oncol. Clin. N. Am. 2006 , 15 , 21 – 37 .
  • Ries , L.A.G. ; Eisner , M.P. ; Kosary , C.L. SEER Cancer Statistics Review. National Cancer Institute http://seer.cancer.gov/csr/1975_2002/ (1975–2002) .
  • American Cancer Society. Colorectal cancer facts & figures, special edition. Atlanta , Georgia : American Cancer Society , 2007.
  • Anthony , T. Colorectal cancer follow-up in 2005 . Surg. Oncol. Clin. N. Am. viii (2006 ), 15 , 175 – 193 .
  • Graffner , H. ; Hultberg , B. ; Johansson , B. ; Moller , T. ; Petersson , B.G. Detection of recurrent cancer of the colon and rectum . J. Surg. Oncol. 1985 , 28 , 156 – 159 .
  • Renehan , A.G. ; Egger , M. ; Saunders , M.P. ; O'Dwyer , S.T. Mechanisms of improved survival from intensive followup in colorectal cancer: a hypothesis . Br. J. Cancer 2005 , 92 , 430 – 433 .
  • et al. . Efficacy and cost of risk-adapted follow-up in patients after colorectal cancer surgery: a prospective, randomized and controlled trial . Eur. J. Surg. Oncol. 2002 , 28 , 418 – 423 .
  • et al. . Role of follow-up in management of local recurrences of colorectal cancer: a prospective, randomized study . Dis. Colon. Rectum. 1998 , 41 , 1127 – 1133 .
  • et al. . Immunohistochemical localization of CEA, CA19-9 and DU-PAN-2 in hepatitis C virus-infected liver tissues . Histopathology 2002 , 40 , 472 – 479 .
  • Maestranzi , S. ; Przemioslo , R. ; Mitchell , H. ; Sherwood , R.A. The effect of benign and malignant liver disease on the tumour markers CA19-9 and CEA . Ann. Clin. Biochem. 1998 , 35 ( Pt 1 ), 99 – 103 .
  • et al. . Carcinoembryonic antigen (CEA) in serum and bile of colorectal cancer patients with or without detectable liver metastases . Anticancer. Res. 1994 , 14 , 1409 – 1412 .
  • Bell , H. ; Orjasaeter , H. Five years’ follow-up of patients with elevated carcinoembryonic antigen (CEA) and alcoholic liver disease, with special reference to mortality rate and development of malignancy . Hepatogastroenterology 1983 , 30 , 140 – 142 .
  • et al. . CEA levels in serum and BAL in patients suffering from lung cancer: correlation with individuals presenting benign lung lesions and healthy volunteers . Med. Oncol. 2007 , 24 , 219 – 225 .
  • Loewenstein , M.S. ; Zamcheck , N. Carcinoembryonic antigen (CEA) levels in benign gastrointestinal disease states . Cancer 1978 , 42 , 1412 – 1418 .
  • Ladenson , J.H. ; McDonald , J.M. ; Landt , M. ; Schwartz , M.K. ( Washington University Case Conference ). Colorectal carcinoma and carcinoembryonic antigen (CEA) . Clin. Chem. 1980 , 26 , 1213 – 1220 .
  • Wang , J.Y. ; Tang , R. ; Chiang , J.M. Value of carcinoembryonic antigen in the management of colorectal cancer . Dis. Colon. Rectum. 1994 , 37 , 272 – 277 .
  • et al. . Preoperative carcinoembryonic antigen level as an independent prognostic factor in colorectal cancer: Taiwan experience . Jpn. J. Clin. Oncol. 2000 , 30 , 12 – 16 .
  • Okholm , M. ; Iversen , L.H. ; Thorlacius-Ussing , O. ; Ejlersen , E. ; Boesby , S. Fibrin and fibrinogen degradation products in plasma of patients with colorectal adenocarcinoma . Dis. Colon. Rectum. 1996 , 39 , 1102 – 1106 .
  • et al. . Fibrinogen catabolism within the procoagulant VX-2 tumor of rabbit lung in vivo: Effluxing fibrin(ogen) fragments contain antiangiogenic activity . J. Lab. Clin. Med. 2004 , 143 , 241 – 254 .
  • et al. . Relationships among tumor burden, tumor size, and the changing concentrations of fibrin degradation products and fibrinolytic factors in the pleural effusions of rabbits with VX2 lung tumors . J. Lab. Clin. Med. 2006 , 147 , 27 – 35 .
  • Baker , E.A. ; Bergin , F.G. ; Leaper , D.J. Plasminogen activator system, vascular endothelial growth factor, and colorectal cancer progression . Mol. Pathol. 2000 , 53 , 307 – 312 .
  • et al. . Effects of urokinase receptor occupancy on plasmin generation and proteolysis of basement membrane by human tumor cells . Blood 1991 , 78 , 479 – 487 .
  • et al. . Plasma urokinase receptor levels in patients with colorectal cancer: relationship to prognosis . J. Natl. Cancer Inst. 1999 , 91 , 869 – 874 .
  • et al. . Expression of tissue factor and vascular endothelial growth factor is associated with angiogenesis in colorectal cancer . Am. J. Hematol. 2002 , 69 , 247 – 254 .
  • et al. . Tissue factor expression in human colorectal carcinoma: correlation with hepatic metastasis and impact on prognosis . Cancer 2000 , 88 , 295 – 301 .
  • et al. . Tissue factor expression and metastatic potential of colorectal cancer . Thromb. Haemost. 1998 , 80 , 894 – 898 .
  • Versteeg , H.H. ; Spek , C.A. ; Peppelenbosch , M.P. ; Richel , D.J. Tissue factor and cancer metastasis: the role of intracellular and extracellular signaling pathways . Mol. Med. 2004 , 10 , 6 – 11 .
  • et al.. Commutators of PAR-1 signaling in cancer cell invasion reveal an essential role of the Rho–Rho kinase axis and tumor microenvironment. Oncogene 2005, 24, 8240–8251.
  • Pepe , M. The Statistical Evaluation of Medical Tests for Classification and Prediction . In Oxford Statistical Science Series 31 ; New York : Oxford University Press , 2003 .
  • et al. . Ovarian Carcinoma: Clinical Validity by Simultaneous Determination of Fibrin Degradation Products with the DR-70™ Immunoassay and CA-125 . German J. Obstetrics and Gynocology 2006 , 66 , 68 – 75 .
  • Li , X. ; Qiao , Z. ; Long , X. ; Wei , J. ; Cheng , Y. Serum concentration of AMDL DR-70 for the diagnosis and prognosis of carcinoma of the tongue . Br. J. Oral. Maxillofac. Surg. 2005 , 43 , 513 – 515 .
  • et al. . The new DR-70 immunoassay detects cancer of the gastrointestinal tract: a validation study . Aliment Pharmacol. Ther. 2004 , 20 , 983 – 987 .
  • et al. . Clinical performance of the AMDL DR-70 immunoassay kit for cancer detection . J. Immunoassay 1998 , 19 , 63 – 72 .
  • Ding , L. ; Ping , S. ; Jingmei , Y. Application of tumor marker of DR-70(R) in the diagnosis of malignant tumors . Chongqing Med. J. 1999 , 28 , 1 – 3 .
  • et al. . Sensitivity & Specificity of DR-70 Lung Cancer Immunoassay . Analytical Letters 1999 , 32 , 1351 – 1362 .
  • et al. . D-dimer–can it be a marker for malignant gastric lesions? Acta. Oncol. 2004 , 43 , 770 – 771 .
  • Rucker , P. ; Antonio , S.M. ; Braden , B. Elevated Fibrinogen-Fibrin Degradation Products (FDP) in Serum of Colorectal Cancer Patients . Analytical Letters 2004 , 37 , 2965 – 2976 .
  • Lee , K.-H. ; Cho , D. ; Kim , K.-M. ; Kim , S.-M. ; Lee , D.-J. Meaning of the DR-70™ Immunoassay for Patients with the Malignant Tumor . Immune Network 2006 , 6 , 43 – 51 .
  • Xu , G. ; Zhang , Y.L. ; Huang , W. Relationship between plasma D-dimer levels and clinicopathologic parameters in resectable colorectal cancer patients . World J. Gastroenterol. 2004 , 10 , 922 – 923 .
  • Oya , M. ; Akiyama , Y. ; Yanagida , T. ; Akao , S. ; Ishikawa , H. Plasma D-dimer level in patients with colorectal cancer: its role as a tumor marker . Surg. Today 1998 , 28 , 373 – 378 .
  • et al. . Plasma fibrin D-dimer levels correlate with tumour volume, progression rate and survival in patients with metastatic breast cancer . Br. J. Cancer 2002 , 86 , 389 – 395 .
  • et al. . Elevated urokinase-type plasminogen activator receptor expression in a colon cancer cell line is due to a constitutively activated extracellular signal-regulated kinase-1-dependent signaling cascade . Oncogene 1997 , 14 , 2563 – 2573 .
  • et al. . Plasminogen/plasmin regulates c-fos and egr-1 expression via the MEK/ERK pathway . Biochem. Biophys. Res. Commun. 2005 , 329 , 237 – 245 .
  • Dvorak , H.F. Thrombosis and cancer . Hum. Pathol. 1987 , 18 , 275 – 284 .
  • Esumi , N. ; Fan , D. ; Fidler , I.J. Inhibition of murine melanoma experimental metastasis by recombinant desulfatohirudin, a highly specific thrombin inhibitor . Cancer Res. 1991 , 51 , 4549 – 4556 .
  • Saksela , O. ; Rifkin , D.B. Cell-associated plasminogen activation: regulation and physiological functions . Annu. Rev. Cell. Biol. 1988 , 4 , 93 – 126 .
  • et al. . Tumor-associated urokinase-type plasminogen activator: biological and clinical significance . Biol. Chem. Hoppe Seyler 1992 , 373 , 611 – 622 .
  • et al. . Fibrin containing gels induce angiogenesis. Implications for tumor stroma generation and wound healing . Lab. Invest. 1987 , 57 , 673 – 686 .
  • et al. . Angiogenic activity of fibrin degradation products is located in fibrin fragment E . J. Pathol. 1992 , 168 , 47 – 53 .
  • et al. . Diverse functions of protease receptor tissue factor in inflammation and metastasis . Immunol. Res. 2000 , 21 , 289 – 292 .
  • Desrosiers , R.R. ; Cusson , M.H. ; Turcotte , S. ; Beliveau , R. Farnesyltransferase inhibitor SCH-66336 downregulates secretion of matrix proteinases and inhibits carcinoma cell migration . Int. J. Cancer 2005 , 114 , 702 – 712 .
  • et al. . Vascular permeability factor, fibrin, and the pathogenesis of tumor stroma formation . Ann. N. Y. Acad. Sci. 1992 , 667 , 101 – 111 .
  • Gasic , G.J. Role of plasma, platelets, and endothelial cells in tumor metastasis . Cancer Metastasis Rev. 1984 , 3 , 99 – 114 .
  • Yan , L. ; Kumagai , S.G. ; McGuire , M.H. ; Yee , J.A. Protease activity and invasion of matrigel by the osteosarcoma-derived OSPR cell line. Biochem. Soc. Trans. 1994, 22, 18S.
  • et al. . Serum levels of vascular endothelial growth factor dependent on the stage progression of lung cancer . Chest 2000 , 118 , 948 – 951 .
  • et al. . Comparison of plasma D-dimer and thrombus precursor protein in patients with operable breast cancer as a potential predictor of lymph node metastasis . Blood Coagul Fibrinolysis 2004 , 15 , 9 – 13 .
  • Oya , M. ; Akiyama , Y. ; Okuyama , T. ; Ishikawa , H. High preoperative plasma D-dimer level is associated with advanced tumor stage and short survival after curative resection in patients with colorectal cancer . Jpn. J. Clin. Oncol. 2001 , 31 , 388 – 394 .
  • et al. . Plasma D-dimer levels in operable breast cancer patients correlate with clinical stage and axillary lymph node status . J. Clin. Oncol. 2000 , 18 , 600 – 608 .
  • et al. . Plasma D-dimer levels show correlation with number of lymph node metastases in patients with esophageal cancer . J. Am. Coll. Surg. 2006 , 202 , 139 – 145 .
  • et al. . Circulating D-dimer levels are better predictors of overall survival and disease progression than carcinoembryonic antigen levels in patients with metastatic colorectal carcinoma . Cancer 2004 , 101 , 77 – 82 .
  • Unsal , E. ; Atalay , F. ; Atikcan , S. ; Yilmaz , A. Prognostic significance of hemostatic parameters in patients with lung cancer . Respir. Med. 2004 , 98 , 93 – 98 .
  • Buccheri , G. ; Torchio , P. ; Ferrigno , D. Plasma levels of D-dimer in lung carcinoma: clinical and prognostic significance . Cancer 2003 , 97 , 3044 – 3052 .
  • et al. . HER-2 gene amplification correlates with higher levels of angiogenesis and lower levels of hypoxia in primary breast tumors . Clin. Cancer Res. 2004 , 10 , 4083 – 4088 .
  • Pavey , S.J. ; Hawson , G.A. ; Marsh , N.A. Impact of the fibrinolytic enzyme system on prognosis and survival associated with non-small cell lung carcinoma . Blood Coagul Fibrinolysis 2001 , 12 , 51 – 58 .
  • et al. . Tissue factor-positive microparticles: cellular origin and association with coagulation activation in patients with colorectal cancer . Thromb Haemost 2007 , 97 , 119 – 123 .